SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: (4aR,4bS,6aS,7S,9aS,9bS,11R,11aS)-N-(2,5-bis(Trifluoromethyl)phenyl)-11-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=CC(N[C@]4([H])[C@H](O)C[C@]32[H])=O)NC5=CC(C(F)(F)F)=CC=C5C(F)(F)F
6β-Hydroxy Dutasteride is chemically (4aR,4bS,6aS,7S,9aS,9bS,11R,11aS)-N-(2,5-bis(Trifluoromethyl)phenyl)-11-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide. 6β-Hydroxy Dutasteride is supplied with detailed characterization data compliant with regulatory guideline. 6β-Hydroxy Dutasteride can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dutasteride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Rapid and Sensitive LC–MS–MS Method for the Simultaneous Estimation of Alfuzosin and Dutasteride in Human Plasma
Noel A. Gomes1,2,&, Ashutosh Pudage2 , Santosh S. Joshi2 , Vikas V. Vaidya1 , Sagar A. Parekh2 , Amod V. Tamhankar
Chromatographia 69(1):9-18
Development and validation of stability indicating RP-HPLC with UV detection method: Analysis of Dutasteride in pharmaceutical dosage forms
Atkuru Veera Venkata Naga Krishna Sunil Kumar1*, Chandra Bala Sekaran2 and Tamanampudi Varahala Reddy3
Journal of Chemical and Pharmaceutical Research, 2015, 7(6):60-70